Abstract

A Therapeutic Helmet Promises Advances in the Treatment of Alzheimer's

(University of Basel, April 11, 2024)

Bottneuro AG co-founders Bekim Osmani, PhD and Prof. Dr. Raphael Guzman, are developing an innovaitve neurostimulator named Miamind, in collaboration with the University of Basel. Built with a focus on treating degenerative diseases like Alzheimer's and Parkinson's, Miamind promises targeted brain electrostimulation at home. The breakthrough of this device lies in employing targeted brain electrostimulation to tackle degenerative conditions like Alzheimer's and Parkinson's disease. This research holds the potential to transform treatments of neurodegenerative diseases, and the device is now undergoing clinical test to confirm its effectiveness.



Original Article on https://www.unibas.ch

Note: Some website previews may not load properly. If nothing appears in this box, access the original webpage directly by clicking its link above.


Science-Switzerland

This article is part of Science-Switzerland produced by Swissnex in Japan as part of the Swissnex Network.
Click here to read the most recent edition, access back numbers or subscribe yourself.